EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.1.2.12 | Anaphylaxis |
10503166 |
A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. |
causal interaction therapeutic application unassigned |
1 2 0 |
3.1.2.12 | Hepatolenticular Degeneration |
3474893 |
Mapping the Wilson disease locus to a cluster of linked polymorphic markers on chromosome 13. |
causal interaction ongoing research unassigned |
2 1 0 |
3.1.2.12 | Hepatolenticular Degeneration |
3856863 |
Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. |
causal interaction unassigned |
1 0 |
3.1.2.12 | Neoplasms |
6877367 |
Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. |
causal interaction unassigned |
4 0 |
3.1.2.12 | Neoplasms |
32757998 |
Phytochemical Profile, and Antiproliferative and Proapoptotic Effects of Pouteria ramiflora (Mart.) Radlk. Leaf Extract, and Its Synergism with Cisplatin in HepG2 Cells. |
causal interaction ongoing research unassigned |
1 4 0 |
3.1.2.12 | Retinoblastoma |
2297043 |
Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity. |
causal interaction unassigned |
3 0 |
3.1.2.12 | Retinoblastoma |
3164261 |
Esterase D: evaluation of a potential derived gene marker for hereditary retinoblastoma. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 2 1 |
3.1.2.12 | Retinoblastoma |
3462714 |
Cloning of the esterase D gene: a polymorphic gene probe closely linked to the retinoblastoma locus on chromosome 13. |
causal interaction ongoing research unassigned |
3 2 0 |
3.1.2.12 | Retinoblastoma |
3502696 |
De novo complex autosomal translocation involving chromosomes 8, 13 and 15 in a girl with a sporadic retinoblastoma. |
causal interaction unassigned |
1 0 |
3.1.2.12 | Retinoblastoma |
3679214 |
Interstitial deletion of chromosome 13 involving the region 13q14. |
causal interaction therapeutic application unassigned |
3 2 0 |